# Yuhwen Chow, M.D. – FDA Inspection, Apr 3, 2023

Source: https://www.keypedia.com/records/fda_inspections/yuhwen-chow-md/622e3045-a29d-45f0-869b-0e316f0f66a2
Source feed: FDA_Inspections

> FDA inspection 1202175 of Yuhwen Chow, M.D., April 03, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202175
- Company Name: Yuhwen Chow, M.D.
- Inspection Date: 2023-04-03
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- Issuing Officer
- [Company Rep](https://www.keypedia.com/people/yuanyuan-li/2043568b-a6ac-4f49-8018-c2c8edda8ac5)

Company: https://www.keypedia.com/companies/yuhwen-chow-md/7df4ded2-01e8-4335-bc9d-905841d3da72

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
